Header Logo

Connection

IRINA AGOULNIK to Adenocarcinoma

Back to Details
This is a "connection" page, showing publications IRINA AGOULNIK has written about Adenocarcinoma.
IRINA AGOULNIK
Connection Strength
0.044
Adenocarcinoma
  1. Suppression of relaxin receptor RXFP1 decreases prostate cancer growth and metastasis. Endocr Relat Cancer. 2010 Dec; 17(4):1021-33.
    View in: PubMed
    Score: 0.025
  2. Relaxin promotes prostate cancer progression. Clin Cancer Res. 2007 Mar 15; 13(6):1695-702.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.